Oyster Point Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch OYST and buy or sell other stocks, ETFs, and their options commission-free!About OYST
Oyster Point Pharma, Inc. engages in the development and commercialization of pharmaceutical therapies to treat ocular surface diseases. Its product candidate, OC-01, is a nicotinic acetylcholine receptor agonist, which is being developed as a nasal spray to treat the signs and symptoms of dry eye disease.
CEOJeffrey A. Nau, PhD
CEOJeffrey A. Nau, PhD
Employees—
Employees—
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded2015
Founded2015
Employees—
Employees—
OYST Key Statistics
Market cap299.85M
Market cap299.85M
Price-Earnings ratio-1.68
Price-Earnings ratio-1.68
Dividend yield—
Dividend yield—
Average volume498.96K
Average volume498.96K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$16.61
52 Week high$16.61
52 Week low$3.46
52 Week low$3.46
Stock Snapshot
Oyster Point Pharma(OYST) stock is priced at $11.17, giving the company a market capitalization of 299.85M. It carries a P/E multiple of -1.68.
On 2026-01-03, Oyster Point Pharma(OYST) stock opened at —, reached a high of —, and a low of —.
Oyster Point Pharma(OYST) shares are trading with a volume of 0, against a daily average of 498.96K.
In the last year, Oyster Point Pharma(OYST) shares hit a 52-week high of $16.61 and a 52-week low of $3.46.
In the last year, Oyster Point Pharma(OYST) shares hit a 52-week high of $16.61 and a 52-week low of $3.46.
People also own
Based on the portfolios of people who own OYST. This list is generated using Robinhood data, and it’s not a recommendation.